NAS
IART icon

Nykredit A/S’s Integra LifeSciences IART Stock Holding History

Nykredit A/S’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.64K Buy
+314
New +$4.39K ﹤0.01% 1911

Other funds holding IART

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

Nykredit A/S's IART Position: Q2 2026 in Review

Nykredit A/S opened a new position in Integra LifeSciences (IART) in Q2 2026: 314 shares worth $5.64K. The stake represents ﹤0.01% of the portfolio and ranks #1911 among its holdings.

151 funds tracked by Wall St. Rank hold IART as of Q2 2026.

  • Nykredit A/S held 314 shares of Integra LifeSciences worth $5.64K as of Q2 2026.
  • Integra LifeSciences was a new Nykredit A/S position in Q2 2026.
  • Integra LifeSciences made up ﹤0.01% of Nykredit A/S's portfolio in Q2 2026, its #1911 holding.
  • 151 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on Nykredit A/S's 13F filing for Q2 2026, filed 13 Aug 2026.